Hypertension: LCZ696, a novel dual inhibitor of neprilysin and the angiotensin II receptor, shows promise in phase II trial
Nat Rev Nephrol
.
2010 Jul;6(7):383.
doi: 10.1038/nrneph.2010.72.
Author
Baldo Lucchese
PMID:
20597156
DOI:
10.1038/nrneph.2010.72
No abstract available
Publication types
Comment